Attention Clinical Trials

158 recruitingLast updated: June 18, 2026

There are 158 actively recruiting attention clinical trials across 32 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3. Top locations include Cincinnati, Ohio, United States, Boston, Massachusetts, United States, New York, New York, United States. Updated daily from ClinicalTrials.gov.


Attention Trials at a Glance

158 actively recruiting trials for attention are listed on ClinicalTrialsFinder across 6 cities in 32 countries. The largest study group is Not Applicable with 93 trials, with the heaviest enrollment activity in Cincinnati, Boston, and New York. Lead sponsors running attention studies include Otsuka Pharmaceutical Co., Ltd., Chinese University of Hong Kong, and Brigham and Women's Hospital.

Browse attention trials by phase

Treatments under study

About Attention Clinical Trials

Looking for clinical trials for Attention? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Attention trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Attention clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 158 trials

Recruiting
Not Applicable

Virtual Reality Mirror Therapy With Focused Object-Directed Attention System

Virtual RealityStrokeRehabilitation+3 more
National Cheng-Kung University Hospital54 enrolled1 locationNCT07525713
Recruiting
Not Applicable

Smartphone-based Intervention for Young Adults With ADHD

Attention Deficit Hyperactivity Disorder (ADHD)Alcohol Use
Traci Kennedy70 enrolled1 locationNCT07654205
Recruiting
Not Applicable

Fronto-Parietal Transcranial Alternating Current Stimulation for ADHD in Children and Adolescents

Attention Deficit Hyperactivity Disorder
Central South University50 enrolled1 locationNCT07633275
Recruiting
Not Applicable

Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD

Attention Deficit Disorder With or Without Hyperactivity (ADHD)
Karolinska Institutet150 enrolled1 locationNCT07614867
Recruiting

Evaluation of the Relationship Between Medication, Eye Movements, and Autonomic Nervous System (ANS) Functions in Children and Adolescents With ADHD

ADHD - Attention Deficit Disorder With Hyperactivity
Umeå University150 enrolled1 locationNCT07634809
Recruiting
Not Applicable

Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder
University of Wisconsin, Madison145 enrolled1 locationNCT02688959
Recruiting
Phase 2

The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder
University of Arkansas, Fayetteville76 enrolled1 locationNCT06115603
Recruiting
Phase 1

A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity DisorderBorderline Personality Disorder
Boehringer Ingelheim96 enrolled9 locationsNCT07001475
Recruiting
Phase 4

Medication Treatment of ADHD in Pediatric Epilepsy

ADHD - Attention Deficit Disorder With Hyperactivity
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.25 enrolled1 locationNCT07594652
Recruiting
Phase 4

Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder Combined
Donald Gilbert, MD, MS, FAAN, FAAP214 enrolled2 locationsNCT04421248
Recruiting
Phase 1Phase 2

Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)
Universidade do Sul de Santa Catarina60 enrolled1 locationNCT07592390
Recruiting
Not Applicable

Intensive-neurofeedback Protocol for Children With ADHD: A Proof-of-concept Study Comparing iAPF-personalized and Standard Theta-beta-ratio Training

ImpulsivityInattentionADHD+2 more
Bielefeld University40 enrolled2 locationsNCT07595783
Recruiting
Not Applicable

Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder (ADHD)
University of Calgary30 enrolled1 locationNCT04532190
Recruiting
Not Applicable

Effects of Transcranial Photobiomodulation in ADHD

Attention Deficit Hyperactivity Disorder
University of Texas at Austin140 enrolled1 locationNCT07203092
Recruiting
Not Applicable

Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

Magnetic Resonance ImagingEcological Momentary AssessmentAttentional Bias+4 more
University of Arkansas255 enrolled1 locationNCT05336188
Recruiting

Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition

ADHDADHD - Attention Deficit Disorder With Hyperactivity
Duke University250 enrolled1 locationNCT06971640
Recruiting
Not Applicable

The Effect of Playful Physiotherapy Intervention

Autism Spectrum DisorderAttention Deficit Hyperactivity Disorder
University of Tartu25 enrolled1 locationNCT07466147
Recruiting
Not Applicable

Effects and Mechanisms of Transcranial Direct Current Stimulation Combined With Dialectical Behavior Therapy Skills Training in Adults With Attention-Deficit/Hyperactivity Disorder

Adult Attention Deficit Hyperactivity Disorder
Nanjing Medical University60 enrolled1 locationNCT07565402
Recruiting
Not Applicable

A Pilot Study of a Remote ADHD Monitoring Program

Attention Deficit Hyperactivity DisorderADHD
IDeA States Pediatric Clinical Trials Network36 enrolled2 locationsNCT06743425
Recruiting
Phase 4

An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening

Attention Deficit Hyperactivity Disorder
NYU Langone Health30 enrolled1 locationNCT06577779